Global Prediabetes Treatment Market Analysis & Forecast Report 2024-2034
April 23, 2024 04:01 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Prediabetes Treatment Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Global Prediabetes Market Analysis Report 2024-2030, Featuring Valbiotis, RESVERLOGIX, Caelus Health, SciMar, Boston Therapeutics, Aphaia Pharma, AstraZeneca and Bristol-Myers Squibb
April 15, 2024 11:18 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global Prediabetes Market Size, Share & Trends Analysis Report by Drug Class (Diguanide, Thiazolidinediones), Age Group (Children, Adult), Region,...
Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
March 13, 2024 14:11 ET
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added...
Type 2 Diabetes Treatment Global Market Outlook Report 2022-2027: Combination of Next Generation Treatments, High Unmet Needs, & Premium Pricing to Drive Growth
January 25, 2023 04:58 ET
|
Research and Markets
Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes Treatment: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In this report, the market has been...
The Worldwide Diabetes Therapeutics Industry is Projected to Reach $3.3 Billion by 2030
October 12, 2022 07:33 ET
|
Research and Markets
Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Diabetes Therapeutics Market By Product: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
Global Diabetes Pipeline Landscape Insights Report, 2021 - Featuring Emerging Drugs Tirzepatide, ORMD-0801, Ladarixin, Enavogliflozin, and DBPR-108
November 26, 2021 07:53 ET
|
Research and Markets
Dublin, Nov. 26, 2021 (GLOBE NEWSWIRE) -- The "Diabetes - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights...